Media

Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.

https://investor.ironwoodpharma.com/press-releases/press-release-details/2019/Ironwood-Pharmaceuticals-and-Alnylam-Pharmaceuticals-Enter-US-GI-Disease-Education-and-Promotional-Agreement-for-Alnylams-Givosiran-in-Acute-Hepatic-Porphyria-AHP/default.aspx

Ironwood has successfully completed the tender offer of VectivBio, a global clinical-stage biotechnology company
pioneering novel, transformational treatments for severe rare gastrointestinal conditions. For more information, click here